Entheon Biomedical Corp. (TSE:ENBI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Entheon Biomedical Corp. has successfully completed a private placement, raising $147,500 through the issuance of 2,950,000 units at $0.05 each, with each unit comprising a common share and a share purchase warrant. The funds will bolster the company’s working capital, with the newly issued securities being subject to a four-month hold period. Entheon Biomedical focuses on developing treatments for addiction and substance use disorders.
For further insights into TSE:ENBI stock, check out TipRanks’ Stock Analysis page.